Clinical definitions of pertussis: Summary of a global pertussis initiative roundtable meeting, february 2011

Clinical Infectious Diseases

Volumn 54, Issue 12, 2012, Pages 1756-1764

  Cherry, James D ^a   Tan, Tina ^b,c   Wirsing Von König, Carl Heinz ^d   Forsyth, Kevin D ^e   Thisyakorn, Usa ^f   Greenberg, David ^g   Johnson, David ^g   Marchant, Colin ^h   Plotkin, Stanley ^g,i  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d Institut fur Hygiene und Laboratoriumsmedizin   (Germany)

^e FLINDERS UNIVERSITY   (Australia)

^f KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^g SANOFI PASTEUR   (France)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PERTUSSIS VACCINE;

APNEA; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BORDETELLA PERTUSSIS; CLINICAL FEATURE; CLINICAL PRACTICE; COMMON COLD; COUGHING; CYANOSIS; DISEASE DURATION; DRUG EFFICACY; EPIDEMIC; EPIDEMIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GLOBAL PERTUSSIS INITIATIVE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTOSIS; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NASOPHARYNGEAL ASPIRATION; NONHUMAN; NOSE SMEAR; PERTUSSIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEIZURE; SENSITIVITY AND SPECIFICITY; SEROLOGY; VACCINATION; VOMITING;

ADOLESCENT; ADULT; ALGORITHMS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; PHYSICAL EXAMINATION; WHOOPING COUGH;

EID: 84861485149     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis302     Document Type: Review

References (36)

1. Cherry JD, Grimprel E, Guiso N, et al. Defining pertussis epidemiology. Pediatr Infect Dis J 2005; 24(5 suppl):S25-4.
2. World Health Organization Department of Vaccines and Biologicals. Pertussis Surveillance: A Global Meeting. WH/V&B/01.19. Geneva: World Health Organization, 2001.
3. Centers for Disease Control and Prevention (CDC). Appendix B. CDC and Council of State and Territorial Epidemiologists (CSTE) pertussis case definition. MMWR Recomm Rep 2006; 55(RR03):36. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a3. htm. Accessed 20 September 2011.
4. Guiso N, Wirsing von König CH, Forsyth K, Tan T, Plotkin SA. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine 2011; 29:1115-21.
5. EU case definition Pertussis: Commission Decision of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No. 2119/98/EC of the European Parliament and of the Council, Official Journal of the European Union. Available at: http://eur lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L: 2008:159:0046:0090: EN:PDF#page=25. Accessed 20 September 2011.
6. Australian National Notifiable Diseases Case Definition: Pertussis. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda- surveil-nndss-casedefs-cd-pertus.htm. Accessed 20 September 2011.
7. PAHO case definition. Available at: http://www.paho.org/english/sha/ be994diphtpert.htm. Accessed 20 September 2011.
8. André P, Caro V, Njamkepo E, et al. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J Clin Microbiol 2008; 46:1672-7. (Pubitemid 351657212)
9. Ghanaie RM, Karimi A, Sadeghi H, et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis 2010; 14:e1072-5.
10. Harnden A, Grant C, Harrison T. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ 2006; 333:174-7. Epub 2006 Jul 7. (Pubitemid 44406743)
11. Wang K, Harnden A. Pertussis-induced cough. Pulm Pharmacol Ther 2011; 24:304-7. Epub 2010 Oct 27.
12. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001; 183:1353-9. (Pubitemid 32337117)
13. Patriarca PA, Biellik RJ, Sanden G, et al. Sensitivity and specificity of clinical case definitions of pertussis. Am J Public Health 1998; 78:833-6.
14. Stehr K, Cherry JD, Heininger U, et al. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics 1998; 101(1 Pt 1): 1-11. (Pubitemid 28030315)
15. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985-9. (Pubitemid 40824285)
16. Wendelboe AM, Njamkep E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293-9. (Pubitemid 46596651)
17. Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007; 26:238-42. (Pubitemid 46340771)
18. Tondella ML, Carlone GM, Messonnier N, et al. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine 2009; 27:803-14.
19. Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention Diagnosis Confirmation. Available at: http://www.cdc.gov/pertussis/clinical/diagnostic-testing/diagnosis-confirmation. html. Accessed 14 February 2011.
20. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:323-82.
21. Mink CM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14:464-71.
22. Schmitt-Grohé S, Cherry JD, Heininger U, et al. Pertussis in German adults. Clin Infect Dis 1995; 21:860-6.
23. Nakamura Y, Kamachi K, Toyoizumi-Ajisaka H, et al. Marked difference between adults and children in Bordetella pertussis DNA load in nasopharyngeal swabs. Clin Microbiol Infect 2011; 17: 365-70.
24. Guiso N, Wirsing von Koenig CH, Forsyth K, Tan T, Plotkin SA. The global pertussis initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine 2011; 29:1115-21.
25. Yih WK, Lett SM, des Vignes FN, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000; 182:1409-16.
26. Marchant CD, Loughlin AM, Lett SM, et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 1994; 169:1297-305. (Pubitemid 24164594)
27. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995; 273: 1044-6.
28. Nenning ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275:1672-4. (Pubitemid 26175816)
29. Vincent JM, Cherry JD, Nauschuetz WF, et al. Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation. Clin Infect Dis 2000; 30:534-9. (Pubitemid 30205301)
30. de Melker HE, Versteegh FG, Schellekens JF, et al. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006; 53:106-13. (Pubitemid 44028673)
31. Kennerknecht N, Riffelmann M, Schmetz J, Wirsing von König CH. Comparison of commercially available immunoblot assays measuring IgG and IgA antibodies to Bordetella pertussis antigens. Eur J Clin Microbiol Infect Dis 2011; 30:1531-5.
32. Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 2010; 48:4459-63.
33. Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH; EU Pertstrain group. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011; 30:307-12.
34. Prince HE, Lapé-Nixon M, Matud J. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies. Clin Vaccine Immunol 2006; 13:266-70. (Pubitemid 43383797)
35. Ward JI, Cherry JD, Chang S-J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353:1555-63. (Pubitemid 41434634)
36. Cherry JD, Heininger U, Stehr K, Christenson P. The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial. Pediatrics 1998; 102(Pt 1):909-12. (Pubitemid 28462533)